These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9205743)

  • 21. Subacute toxicity of ebrotidine in rats and dogs.
    Romero A; Grau MT; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):492-7. PubMed ID: 9205751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
    Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ebrotidine on gastric mucosal calcium channel activity.
    Slomiany BL; Liu J; Kawai T; Czajkowski A; Slomiany A
    Am J Gastroenterol; 1993 Jun; 88(6):881-6. PubMed ID: 8099251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
    Agut J; Sánchez JC; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.
    Slomiany BL; Liu J; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
    J Physiol Pharmacol; 1994 Mar; 45(1):121-31. PubMed ID: 7519082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ebrotidine in healthy volunteers. A summary.
    Albet C; Pérez JA; Rozman E; Márquez M; Herrero E; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):535-9. PubMed ID: 9205760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol.
    Slomiany BL; Piotrowski J; Murty VL; Slomiany A
    Gen Pharmacol; 1992 Jul; 23(4):719-27. PubMed ID: 1356875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Aug; 30(6):1127-34. PubMed ID: 8106073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of ebrotidine on reproduction. Toxicity on fertility and general reproductive performance, embryo-fetal toxicity and peri- and postnatal toxicity.
    Romero A; Grau MT; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):504-10. PubMed ID: 9205753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro anti-Helicobacter pylori activity of ebrotidine.
    Palacín C; Tarragó C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):471-4. PubMed ID: 9205746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and assessment of formamidines as new histamine H2-receptor antagonists.
    Anglada L; Raga M; Márquez M; Sacristán A; Castelló JM; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):431-4. PubMed ID: 9205738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of ebrotidine and ranitidine in the treatment of benign gastric ulcer.
    Gedliczka O; Bobrzynski A; Rembiasz K; Fillat O; Torres J; Herrero E; Márquez M; Camps F; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):560-4. PubMed ID: 9205765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
    Slomiany BL; Lopez RA; Slomiany A
    Biochem Int; 1992 Dec; 28(4):665-74. PubMed ID: 1482403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ebrotidine on the density of antral G-cells in the gastric mucosa in the rat.
    Romero A; Gómez F; Villamayor F; Sacristán A; Ortíz JA
    Cell Prolif; 1995 Jul; 28(7):393-401. PubMed ID: 7548440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ebrotidine versus ranitidine in the healing and prevention of relapse of duodenal ulcer. A multicentre, double-blind, parallel, randomized, controlled study.
    Tulassay Z; Döbrönte Z; Farkas I; Juhász L; Simon L; Prónai L; Torres J; Márquez M
    Arzneimittelforschung; 1997 Apr; 47(4A):551-5. PubMed ID: 9205763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroprotective and ulcer-healing activities of a new H2-receptor antagonist: ebrotidine.
    Brzozowski T; Majka J; Konturek SJ
    Digestion; 1992; 51(1):27-36. PubMed ID: 1353465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical properties, analytical determinations and stability of ebrotidine.
    Albet C; Fernández JM; Castelló JM; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):435-8. PubMed ID: 9205739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of combination treatment with famotidine and methylmethionine sulfonium chloride on the mucus barrier of rat gastric mucosa.
    Ichikawa T; Ito Y; Saegusa Y; Iwai T; Goso Y; Ikezawa T; Ishihara K
    J Gastroenterol Hepatol; 2009 Mar; 24(3):488-92. PubMed ID: 19175830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroprotective and antisecretory effects of ebrotidine.
    Konturek SJ; Maczka J; Kaminski K; Sito E; Torres J; Oleksy J
    Scand J Gastroenterol; 1992 Jun; 27(6):438-42. PubMed ID: 1352908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.